Reduced efflux function of enterocyte P-gp transporter, and thus less efficient secretion of its substrates back to the intestinal lumen in kidney failure, may contribute to increased drug concentrations, apart from reduced P-gp mediated elimination through the kidney. This evidence concerns the gene PGP and kidney failure.